United StatesÚltimas notícias

FedEx (NYSE:FDX) reported fourth-quarter fiscal 2026 revenue of $25 billion and adjusted earnings per share of $6.60, driven by higher volumes and cost efficiency initiatives.

A global selloff in the shares of chipmakers dragged US indexes sharply lower amid doubts about the sustainability of the AI-fueled tech rally. Katherine Kostereva, CEO, Creatio joined Bloomberg Businessweek Daily to discuss.

Strive Inc. Chief Executive Officer Matt Cole says this is a great time to buy Bitcoin as the price keeps falling. He says their Bitcoin holdings are up to 20,000 from 5,000 last fall. He speaks on "Bloomberg Crypto."

Mike Sommers, president of the American Petroleum Institute, joined Balance of Power to discuss the American Energy Security Framework. Sommers said the nation's Strategic Petroleum Reserve is "in desperate need of upgrading."

New York City is experiencing a highly contested Congressional primary season with a number of hotly contested races. The primaries will test the political strength of New York City Mayor Zohran Mamdani, who has endorsed several insurgent candidates against Democratic stalwarts, and will speak to demographic and generational shifts within the party. Daniel Squadron, former New York State Senator (D) and co-founder of The States Project, author of the new book "The Fourth Branch" joins to discuss on Balance of Power.

President Donald Trump said Iran will only be able to use funds released from frozen accounts to purchase food and medical supplies from the US, seeking to ease concerns about peace negotiations that both sides say are making progress.  Brett Bruen, President of the Global Situation Room and former White House Director of Global Engagement joined Balance of Power to discuss.

Worthington Enterprises (NYSE:WOR) declared a quarterly dividend of $0.20 per share, marking a 5% increase from the prior quarter.

US tech stocks join a global selloff as investors reassess the AI trade. Amanda Agati, Chief Investment Officer at PNC Asset Management Group, says the tech pullback is a healthy reset after an extraordinary run. She speaks on "Bloomberg Open Interest."

When Dave Ricks became chief executive officer of Eli Lilly & Co. in 2017, he was facing an industry under siege. Americans held drug companies in lower esteem than airlines, law firms and even the federal government. President Donald Trump, then starting his first term, was excoriating them for their high prices. A mounting number of reports showed that soaring costs were even forcing some diabetics to ration insulin. Ricks, the 11th CEO in Lilly's 150-year history, concedes that one was a public-relations nightmare. Almost a decade later, the mood at Lilly has shifted dramatically. The company's hit diabetes shot, Mounjaro, and obesity shot, Zepbound, have transformed its fortunes and, in many ways, its public image. We speak with Madison Muller, Bloomberg News Healthcare Reporter, for a closer look.

SpaceX has drawn about $89 billion of demand for its debut US bond sale, according to people with knowledge of the matter, setting the stage for one of the biggest deals in the US investment-grade market this year. Elon Musk's rocket, satellite and AI conglomerate is seeking to raise between $20 billion and $25 billion from the five-tranche offering in a deal that's expected to price on Tuesday. At the lower of that range, demand would exceed the bond size by more than four times. Debt investors, who tend to be more conservative than those in the equity market, are betting on Musk's ability to deliver on his promises even as the company is projected to burn significant amounts of cash over the next few years. For more, we speak with Robert Schiffman, Senior Tech Credit Analyst for Bloomberg Intelligence.

AI is moving beyond chatbots and onto the factory floor, helping manufacturers boost productivity. Siemens CEO Roland Busch joins Ed Ludlow on "Bloomberg Tech" to discuss the trend and AI's role in Europe's industrial future.

Meta, which helped popularize smart glasses through partnerships with Ray-Ban and Oakley, is going down-market by launching lower-priced models under its own brand for the first time. Bloomberg's Mark Gurman joins Ed Ludlow on "Bloomberg Tech."